Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CD79b-19 CAR T cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
CD79b-19 CAR T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting both CD79b and CD19 expressed on tumor cells, potentially leading to cytotoxicity against tumor cells and inhibition of tumor growth (PMID: 31439577). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CD79b-19 CAR T cells | CD79b-19 CAR T cells | 0 | 1 |